News

A recent study provides some evidence of the ability to potentially reduce belimumab dose in a subset of patients with SLE.

A study describes the structure and function differences of the Achilles tendon for PsA patients who self-report pain and those who don’t.

A recent study suggests fibromyalgia has little effect on polysomnographic indicators of obstructive sleep apnea-hypopnea syndrome.

A study examines why patients with inflammatory arthritis might seek emergency department care over ambulatory care.

At EULAR, Tonix Pharmaceuticals presented the phase 3 RESILIENT trial which met the primary endpoint of TNX-102 SL reducing daily pain intensity.

Patients with psoriasis on biological agents might have a lower PsA risk than those on methotrexate, but patients on topical therapy have an even lower risk, a study found.

Among patients with PsA, men tend to present more peripheral joint movement, and women tend to exhibit more axial involvement, a new study found.

These findings, presented at RAD 2024, highlight risk of atopic dermatitis patients for developing various cancers as well as major adverse cardiovascular events.

Some of the risk factors for RA-interstitial lung disease include male sex, older age, and smoking history, a study found.

An analysis of the REALISTIC trial from EULAR 2024 details the effects of certolizumab pegol in rheumatoid arthritis based on rheumatoid factor levels and prior TNF inhibitor use.

Findings highlight significant improvements in psychological constructs related to pain and quality of life following an 8-week intervention with hyperbaric oxygen therapy.

A new study found an indirect effect of RA on frailty index through inflammatory cytokines.

Findings highlight an urgent need for improved gout management strategies to reduce costs, improve quality of life, and reduce gout symptoms in patients with comorbid gout and CKD.

A propensity score matched analysis suggests use of SGLT2 inhibitors could reduce risk of negative outcomes in patients with systemic lupus erythematosus and type 2 diabetes.

Urate-lowering therapy was strongly associated with successful treat-to-target benchmarks in gout, including serum uric acid levels, but adherence remained low.

Exactly half of the sample had previously read or applied ≥ 1 Clinical Practice Guideline in the field of fibromyalgia.

Adults with active PsA treated with guselkumab exhibited durable achievement of study endpoints associated with disease control, irrespective of baseline characteristics.

An analysis of CDC WONDER data details disparities among the cardiovascular mortality rate for patients with rheumatoid arthritis in the US.

The approval was based on previous data from well-controlled RA studies coupled with findings from a multinational, dose-finding study of pediatric patients with pJIA.

Patients in the active counseling group were more likely to achieve low disease activity or remission.

Participants said the process was easy, convenient, and informed their self-management behaviors.

The rheumatology month in review addresses opioid concerns and promotes holistic care in managing chronic conditions.

cfPWV values were significantly higher in patients with PsA compared with controls, even after adjusting for confounders.

The approvals were based on data from well-controlled studies of the drug in adult patients with PsA and RA.

A significantly greater improvement in total FIQ scores was observed among patients with fibromyalgia receiving rTMS compared with placebo.

The analysis of NHANES data revealed a dose-response association between weekly moderate-to-vigorous physical activity levels and hyperuricemia risk.

In a new study, 16% of patients with RA and 22% with PsA had sleeping issues during the last week.

A binary logistic regression analysis recognized factors significantly linked to an increased prevalence of gout, including sex, a history of renal disease or diabetes mellitus, and podagra.

Among included RA studies, 83.3% showed significantly better clinical outcomes in patients managed with a T2T strategy compared with usual care.

As the severity of rheumatoid arthritis disease activity increases, so does the prevalence of depression, a new study found.